Reference health

The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis

https://doi.org/10.1056/nejmoa022436
CiteStamped reference-health badge
29/29 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 29 checked references that resolve
resolves10.7326/0003-4819-128-10-199805150-00001
The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A Prospective Study
resolves10.1359/jbmr.1997.12.1.24
Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation
resolves10.1001/jama.285.3.320
Risk of New Vertebral Fracture in the Year Following a Fracture
resolves10.1002/jbmr.5650090503
Risk of hip fracture in women with vertebral fracture
resolves10.1016/S0140-6736(02)08706-8
Pathogenesis of bone fragility in women and men
resolves10.1016/S0140-6736(96)07088-2
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
resolves10.1007/s001980050010
Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
resolves10.1001/jama.282.7.637
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
resolves10.7326/0003-4819-117-1-1
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
resolves10.1016/S8756-3282(00)00376-8
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women
resolves10.1172/JCI119668
Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
resolves10.1056/NEJM200105103441904
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
resolves10.1007/s002230010055
Mechanisms of Action and Therapeutic Potential of Strontium in Bone
resolves10.1016/8756-3282(96)00080-4
The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro
resolves10.1016/S8756-3282(01)00484-7
Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis)
resolves10.1002/jbmr.5650080512
An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats
resolves10.1016/8756-3282(90)90086-E
Effects of low doses of strontium on bone quality and quantity in rats
resolves10.1002/jbmr.5650110915
Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration
resolves10.1210/jc.87.5.2060
Strontium Ranelate: Dose-Dependent Effects in Established Postmenopausal Vertebral Osteoporosis--A 2-Year Randomized Placebo Controlled Trial
resolves10.1002/jbmr.5650080915
Vertebral fracture assessment using a semiquantitative technique
resolves10.1002/jbmr.5650110716
Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis
resolves10.1007/BF01622258
Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures
resolves10.1385/JCD:2:1:37
The Use of Different Dual X-Ray Absorptiometry Brands in a Multicenter Clinical Trial
resolves10.1007/s001980070007
Markers of Bone Turnover for Monitoring Treatment of Osteoporosis with Antiresorptive Drugs
resolves10.1016/S0140-6736(97)02342-8
Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis
resolves10.1056/NEJMoa031975
The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis
resolves10.1016/S1094-6950(06)60402-2
Influence of Strontium on Bone Mineral Density and Bone Mineral Content Measurements by Dual X-Ray Absorptiometry
resolves10.1016/S8756-3282(01)00419-7
Incorporation and distribution of strontium in bone
resolves10.1007/s001980200129
Prevention of Early Postmenopausal Bone Loss by Strontium Ranelate: The Randomized, Two-Year, Double-Masked, Dose-Ranging, Placebo-Controlled PREVOS Trial
The 1 reference without a DOI — listed, not checked
no DOI — not checkedr014
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1056/nejmoa022436"><img src="https://citestamp.com/citestamped/10.1056/nejmoa022436/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1056/nejmoa022436/badge.svg)](https://citestamp.com/citestamped/10.1056/nejmoa022436)